Bisphosphonates act directly on the osteoclast to induce caspase cleavage of Mst1 kinase during apoptosis - A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase

被引:214
作者
Reszka, AA [1 ]
Halasy-Nagy, JM [1 ]
Masarachia, PJ [1 ]
Rodan, GA [1 ]
机构
[1] Merck Res Labs, Dept Bone Biol & Osteoporosis Res, W Point, PA 19486 USA
关键词
D O I
10.1074/jbc.274.49.34967
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bisphosphonates (BPs) include potent inhibitors of bone resorption used to treat osteoporosis and other bone diseases. BPs directly or indirectly induce apoptosis in osteoclasts, the bone resorbing cells, and this mag play a role in inhibition of bone resorption, Little is known about downstream mediators of apoptosis in osteoclasts, which are difficult to culture. Using purified osteoclasts, we examined the effects of alendronate, risedronate, pamidronate, etidronate, and clodronate on apoptosis and signaling kinases, All BPs induce caspase-dependent formation of pyknotic nuclei and cleavage of Mammalian Sterile 20-like (Mst) kinase 1 to form the active 34-kDa species associated with apoptosis. Withdrawal of serum and of macrophage colony stimulating factor, necessary for survival of purified osteoclasts, or treatment with staurosporine also induce apoptosis and caspase cleavage of Mst1, Consistent with their inhibition of the mevalonate pathway, apoptosis and cleavage of Mst1 kinase induced by alendronate, risedronate, and lovastatin, but not clodronate, are blocked by geranylgeraniol, a precursor of geranylgeranyl diphosphate. Together these findings suggest that BPs act directly on the osteoclast to induce apoptosis and that caspase cleavage of Mst1 kinase is part of the apoptotic pathway, For alendronate and risedronate, these events seem to be downstream of inhibition of geranylgeranylation.
引用
收藏
页码:34967 / 34973
页数:7
相关论文
共 28 条
[1]   Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry [J].
Auriola, S ;
Frith, J ;
Rogers, MJ ;
Koivuniemi, A ;
Mönkkönen, J .
JOURNAL OF CHROMATOGRAPHY B, 1997, 704 (1-2) :187-195
[2]  
Coxon FP, 1998, MOL PHARMACOL, V54, P631
[3]   The Ste20-like protein kinase, Mst1, dimerizes and contains an inhibitory domain [J].
Creasy, CL ;
Ambrose, DM ;
Chernoff, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (35) :21049-21053
[4]   The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H+-ATPase [J].
David, P ;
Nguyen, H ;
Barbier, A ;
Baron, R .
JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 (10) :1498-1507
[5]   Alendronate mechanism of action:: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro [J].
Fisher, JE ;
Rogers, MJ ;
Halasy, JM ;
Luckman, SP ;
Hughes, DE ;
Masarachia, PJ ;
Wesolowski, G ;
Russell, RGG ;
Rodan, GA ;
Reszka, AA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :133-138
[6]   Bisphosphonates: Mechanisms of action [J].
Fleisch, H .
ENDOCRINE REVIEWS, 1998, 19 (01) :80-100
[7]   Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta,gamma-dichloromethylene) triphosphate, by mammalian cells in vitro [J].
Frith, JC ;
Monkkonen, J ;
Blackburn, GM ;
Russell, RGG ;
Rogers, MJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (09) :1358-1367
[8]   MICROTUBULE-ASSOCIATED-PROTEIN (MAP) KINASE ACTIVATED BY NERVE GROWTH-FACTOR AND EPIDERMAL GROWTH-FACTOR IN PC12 CELLS - IDENTITY WITH THE MITOGEN-ACTIVATED MAP KINASE OF FIBROBLASTIC CELLS [J].
GOTOH, Y ;
NISHIDA, E ;
YAMASHITA, T ;
HOSHI, M ;
KAWAKAMI, M ;
SAKAI, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 193 (03) :661-669
[9]   Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1 [J].
Graves, JD ;
Gotoh, Y ;
Draves, KE ;
Ambrose, D ;
Han, DKM ;
Wright, M ;
Chernoff, J ;
Clark, EA ;
Krebs, EG .
EMBO JOURNAL, 1998, 17 (08) :2224-2234
[10]  
HUGHES DE, 1995, J BONE MINER RES, V10, P1478